From immune checkpoints and cytokines to viral antigens and amyloids, our in silico platform supports the design of monoclonal antibodies, bispecifics and nanobodies against structurally characterized targets - with a focus on candidates ready to move towards the clinic.
Each target page provides in-depth scientific analysis, engineering approach, clinical landscape, and the MAbSilico database profile. Click any card to explore.
PD-1, LAG-3, TIGIT, TIM-3 targets in preparation.
Request a targetMore infectious disease targets coming soon — request a target
VEGF-C, PDGFR, HER2 targets in preparation — request a target
Our 6-step workflow runs on top of every target in this library.
Our platform handles any target with an available 3D model. Tell us about your project and we’ll come back with a feasibility note.